RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$16.27
Tradestie Score
41
Market Cap
$2.89B
Revenue Growth
0.1%
Analyst Upside
+55.8%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.04
|
$1.84B | - | 40 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.48
|
$1.81B | - | 48 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.62
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.01
|
$1.78B | - | 49 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$114.22
|
$1.77B | - | 53 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.48
|
$1.74B | - | 42 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.53
|
$1.68B | - | 49 | Compare |
|
MNKD
Mannkind Corporation
|
$4.16
|
$1.65B | - | 32 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$45.82
|
$1.63B | 5.7 | 37 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.07
|
$1.57B | - | 41 | Compare |
More RARE Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry